Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Finasteride helps female-pattern hair loss.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

PAD type III enzyme is specific to rat skin and hair follicles.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Changing YBX1 protein activity affects skin stem cell function and aging.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

Gab1 protein is crucial for hair growth and stem cell renewal, and Mapk signaling helps maintain these processes.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Norgalanthamine helps hair cells grow by activating certain pathways related to hair growth.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

JAK inhibitors are effective and safe for treating severe alopecia areata.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

AKR1B10 enzyme may cause keloid scars and could be a treatment target.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Keratin 17 is crucial for cell growth in wound healing by aiding protein synthesis.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.